MARKET

CERS

CERS

Cerus
NASDAQ
1.725
-0.075
-4.17%
Opening 12:40 06/14 EDT
OPEN
1.780
PREV CLOSE
1.800
HIGH
1.800
LOW
1.720
VOLUME
213.24K
TURNOVER
0
52 WEEK HIGH
3.080
52 WEEK LOW
1.205
MARKET CAP
318.94M
P/E (TTM)
-9.9024
1D
5D
1M
3M
1Y
5Y
Cerus Corporation Celebrates World Blood Donor Day 2024
In 2005, the World Health Assembly designated June 14 as World Blood Donor Day to recognize and thank blood donors across the world for their important contributions to the global blood supply. Cerus Corporation will celebrate World Blooddonor Day 2024. The focus of the day is on all blood donors. More than 118.5 million blood donations are collected annually.
Barchart · 9h ago
Cerus Stockholders Endorse New Plans and Board Members
TipRanks · 2d ago
Weekly Report: what happened at CERS last week (0603-0607)?
Weekly Report · 4d ago
Cerus: Statement of changes in beneficial ownership of securities
Press release · 06/07 00:03
Weekly Report: what happened at CERS last week (0527-0531)?
Weekly Report · 06/03 11:24
Weekly Report: what happened at CERS last week (0520-0524)?
Weekly Report · 05/27 11:29
Weekly Report: what happened at CERS last week (0513-0517)?
Weekly Report · 05/20 11:22
Zomedica And 3 Other Stocks Under $3 Insiders Are Buying
Dow Jones index closed lower by over 80 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Recent notable insider transactions for penny stocks include Earth Science Tech, Inc. And Zomedica Corp.
Benzinga · 05/14 13:01
More
About CERS
Cerus Corporation is a biomedical products company. The Company is focused on developing and commercializing the INTERCEPT Blood System to enhance blood safety. The INTERCEPT Blood System, which is based on its proprietary technology for controlling biological replication, is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. Its INTERCEPT Blood System is intended for use with blood components and certain of their derivatives: platelets, plasma, red blood cells and to produce INTERCEPT Fibrinogen Complex (IFC), and pathogen reduced plasma, cryoprecipitate reduced. The INTERCEPT Blood System for Cryoprecipitation uses its plasma system to produce IFC for the treatment and control of bleeding, including massive hemorrhage, associated with fibrinogen deficiency. In addition, the INTERCEPT Blood System for Cryoprecipitation is used to produce pathogen reduced plasma, cryoprecipitate reduced.

Webull offers Cerus Corp stock information, including NASDAQ: CERS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CERS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CERS stock methods without spending real money on the virtual paper trading platform.